AU6919598A - A novel bioadhesive drug delivery system based on liquid crystals - Google Patents

A novel bioadhesive drug delivery system based on liquid crystals

Info

Publication number
AU6919598A
AU6919598A AU69195/98A AU6919598A AU6919598A AU 6919598 A AU6919598 A AU 6919598A AU 69195/98 A AU69195/98 A AU 69195/98A AU 6919598 A AU6919598 A AU 6919598A AU 6919598 A AU6919598 A AU 6919598A
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
system based
liquid crystals
bioadhesive drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69195/98A
Inventor
Lise Sylvest Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Dumex Alpharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex Alpharma AS filed Critical Dumex Alpharma AS
Publication of AU6919598A publication Critical patent/AU6919598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
AU69195/98A 1997-04-17 1998-04-17 A novel bioadhesive drug delivery system based on liquid crystals Abandoned AU6919598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK43597 1997-04-17
DK435/97 1997-04-17
PCT/DK1998/000159 WO1998047487A1 (en) 1997-04-17 1998-04-17 A novel bioadhesive drug delivery system based on liquid crystals

Publications (1)

Publication Number Publication Date
AU6919598A true AU6919598A (en) 1998-11-13

Family

ID=8093507

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69195/98A Abandoned AU6919598A (en) 1997-04-17 1998-04-17 A novel bioadhesive drug delivery system based on liquid crystals

Country Status (5)

Country Link
EP (1) EP0975331A1 (en)
JP (1) JP2001524958A (en)
AU (1) AU6919598A (en)
CA (1) CA2286052A1 (en)
WO (1) WO1998047487A1 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
ES2231263T3 (en) * 1999-08-06 2005-05-16 Max-Delbruck-Centrum Fur Molekulare Medizin SUSTAINABLE ACTIVE PRINCIPLE SUSTAINED RELEASE SYSTEMS.
US6465002B1 (en) 2000-03-13 2002-10-15 Brown University Research Foundation Liquid crystalline polymers
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057770A1 (en) * 2000-11-22 2002-05-23 Beiersdorf Ag Cosmetic or dermatological composition comprises dispersed liquid crystals forming a cubic phase
DE10057767A1 (en) * 2000-11-22 2002-05-23 Beiersdorf Ag Deodorant and antiperspirant composition comprises dispersed liquid crystals forming a cubic phase
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6936187B2 (en) * 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
JP2005532366A (en) * 2002-06-13 2005-10-27 リオトロピック セラピュティックス アイエヌシー． Reverse liquid crystal phase with non-paraffinic hydrophobic material
KR100533460B1 (en) * 2002-07-20 2005-12-08 대화제약 주식회사 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2007504256A (en) * 2003-09-01 2007-03-01 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド Compositions and methods for delivery of bioactive agents
PL1843746T3 (en) * 2005-01-14 2011-09-30 Camurus Ab Somatostatin analogue formulations
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
EP2206495B1 (en) 2005-01-14 2012-11-21 Camurus AB Topical bioadhesive formulations
CA2594710C (en) * 2005-01-14 2011-01-25 Camurus Ab Topical bioadhesive formulations
ATE501710T1 (en) 2005-01-14 2011-04-15 Camurus Ab SOMATOSTATIN ANALOG FORMULATIONS
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
JP5127466B2 (en) * 2005-01-21 2013-01-23 カムルス エービー Pharmaceutical lipid composition
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
EP1878425A4 (en) * 2005-04-28 2009-08-26 Japan Science & Tech Agency Transdermal absorption accelerator
CN101217940B (en) 2005-06-06 2013-03-27 卡穆鲁斯公司 Glp-1 analogue formulations
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
DE602007009377D1 (en) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc SECONDARY FLOW MODULATOR WITH AN INTERNAL CHANNEL FOR AN OSMOTIC OUTPUT SYSTEM
KR101200728B1 (en) 2006-08-09 2012-11-13 인타르시아 세라퓨틱스 인코포레이티드 Osmotic delivery system and piston assemblies
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
EP2498754B1 (en) * 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonal mesophases (h ii) and uses thereof
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
KR101494594B1 (en) 2011-08-30 2015-02-23 주식회사 종근당 Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same
EP2810657B1 (en) * 2012-01-31 2016-09-21 Santen Pharmaceutical Co., Ltd Non-aqueous liquid composition
SG11201407678YA (en) 2012-05-25 2014-12-30 Camurus Ab Somatostatin receptor agonist formulations
KR101586791B1 (en) 2012-12-28 2016-01-19 주식회사 종근당 Sustained-release lipid pre-concentrate of GnRH analogues and pharmaceutical composition comprising the same
JP6289075B2 (en) * 2013-01-25 2018-03-07 ロート製薬株式会社 Composition for external use
KR101601035B1 (en) 2013-02-28 2016-03-08 주식회사 종근당 Composition for gene delivery comprising chitosan and liquid crystal formation material
CA2947308A1 (en) * 2013-05-09 2014-11-13 Zeenar Enterprises Pty Ltd Niacin formulation
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016195338A2 (en) * 2015-05-29 2016-12-08 서울대학교산학협력단 Liquid crystal nanoparticles, preparation method therefor, drug delivery system containing lipophilic drug-incorporated liquid crystal nanoparticles
KR20240042548A (en) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 Implant placement and removal systems
MA53353A (en) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc GLUCAGON RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS FOR THEIR USE
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
CN114632059A (en) * 2020-12-15 2022-06-17 南京海辰药业股份有限公司 Intravenous infusion liquid preparation containing Reidesvir and preparation method thereof
CN112791047A (en) * 2021-01-15 2021-05-14 中国人民解放军总医院第三医学中心 Resveratrol lamellar liquid crystal and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
SE9200952D0 (en) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab PHARMACEUTICAL CARRIER SYSTEM CONTAINING DEFINED LIPIDS
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
SE518578C2 (en) * 1994-06-15 2002-10-29 Gs Dev Ab Lipid-based composition
EP0871489A1 (en) * 1995-10-12 1998-10-21 Gs Development Ab A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Also Published As

Publication number Publication date
JP2001524958A (en) 2001-12-04
EP0975331A1 (en) 2000-02-02
CA2286052A1 (en) 1998-10-29
WO1998047487A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
AU6919598A (en) A novel bioadhesive drug delivery system based on liquid crystals
AU5859096A (en) Vial adaptor for a liquid delivery device
AU664807B2 (en) Drug delivery system
AU5902998A (en) Medicine vial dispenser
AU1714999A (en) Pill dispensing system
AU5898598A (en) Liquid delivery systems
EP0774955A4 (en) Improved bioadhesive pharmaceutical delivery system
AU4652596A (en) Liquid polymer delivery system
AU6180898A (en) Reliable event delivery system
AU3911597A (en) Dispensing apparatus including a pump package system
AU6876498A (en) Intravesical drug delivery system
AU3904099A (en) Drug delivery module
AU8244598A (en) Liquid crystal display
AU8130598A (en) Liquid crystal display
AU6234798A (en) A medicament dispense sensing device
AU1713799A (en) Product delivery device
AU8461398A (en) Liquid crystal display
AU6377198A (en) A delivery device
AU3154895A (en) Tastemasked liquid pharmaceutical delivery system
AU2999995A (en) Self-emulsifying drug delivery system
AU7711098A (en) Drug delivery system
AU8128698A (en) Liquid crystal display
AU7201998A (en) Drug delivery system
AU8461198A (en) Liquid crystal display
AU6842898A (en) Integrated dispense system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase